A phase III randomized controlled trial of anastrozole compared to anastrozole plus fulvestrant as adjuvant endocrine therapy for postmenopausal women with estrogen receptor +/- progesterone receptor positive breast cancer
Phase of Trial: Phase III
Latest Information Update: 05 Dec 2008
At a glance
- Drugs Anastrozole (Primary) ; Fulvestrant (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 05 Dec 2008 Last checked against National Cancer Institute of Canada record.
- 04 Apr 2007 New trial record.